The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and New: An FDA decision to place 19 peptides on the unsafe list was supported by numerous documented safety concerns, former officials said. Even though demand for peptide therapies has exploded since then, Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law Compounded "semaglutide" is not FDA approved semaglutide.com The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and Is BPC 157 Banned? Oral vs. Injectable Forms Explained